-logo-1200x675.png?v=20220915161652&w=240&h=240&zc=2){kind=logo}
Context Therapeutics Inc. (NASDAQ:CNTX) Receives $6.33 Average PT from Analysts
Context Therapeutics Inc. (NASDAQ:CNTX – Get Free Report) has received an average rating of “Buy” from the seven brokerages that are currently covering the company, Marketbeat.com reports. Six equities research analysts have rated the stock with a buy recommendation and one has given a strong buy recommendation to the company. The average 12-month price target […]
Context Therapeutics Inc. (NASDAQ:CNTX – Get Free Report) has received an average rating of “Buy” from the seven brokerages that are currently covering the company, Marketbeat.com reports. Six equities research analysts have rated the stock with a buy recommendation and one has given a strong buy recommendation to the company. The average 12-month price target […]
